ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global GLP-1 Weight Loss Drug Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-6T15899
Home | Market Reports | Health| Pharmacy
Global GLP 1 Weight Loss Drug Market Research Report 2023
BUY CHAPTERS

Global GLP-1 Weight Loss Drug Market Research Report 2025

Code: QYRE-Auto-6T15899
Report
May 2025
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novo Nordisk
Astrazeneca plc
Eli Lilly
Sanofi
Benemae
Chiatai Tianqing
Tonghua Dongbao Pharmaceutical
Huadong Medicine
HANSOH PHARMLA

GLP-1 Weight Loss Drug Market

The global market for GLP-1 Weight Loss Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
GLP-1 (Glucagon-Like Peptide-1) weight loss drugs are a class of drugs used to treat obesity and control weight. GLP-1 is a naturally occurring insulin-releasing hormone produced by cells in the small intestine after food ingestion and has multiple physiological effects, including stimulating insulin secretion and inhibiting gastric emptying, thereby slowing the passage of food through the gastrointestinal tract. GLP-1 weight loss drugs simulate the biological activity of GLP-1 and trigger a series of physiological reactions, which help reduce appetite, increase satiety, and reduce calorie intake, thereby helping people lose weight. This class of drugs is often used to treat obesity, especially in obese patients who are at risk for diabetes.
North American market for GLP-1 Weight Loss Drug is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for GLP-1 Weight Loss Drug is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of GLP-1 Weight Loss Drug include Novo Nordisk, AstraZeneca, Eli Lilly, Sanofi, BENEMAE, HANSOH PHARMLA, CHIATAI TIANQING, Tonghua Dongbao Pharmaceutical, Huadong Medicine, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for GLP-1 Weight Loss Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GLP-1 Weight Loss Drug.
The GLP-1 Weight Loss Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global GLP-1 Weight Loss Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the GLP-1 Weight Loss Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of GLP-1 Weight Loss Drug Market Report

Report Metric Details
Report Name GLP-1 Weight Loss Drug Market
Segment by Type
Segment by Application
  • Online Pharmacy
  • Offline Pharmacy
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novo Nordisk, AstraZeneca, Eli Lilly, Sanofi, BENEMAE, HANSOH PHARMLA, CHIATAI TIANQING, Tonghua Dongbao Pharmaceutical, Huadong Medicine
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of GLP-1 Weight Loss Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of GLP-1 Weight Loss Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the GLP-1 Weight Loss Drug Market report?

Ans: The main players in the GLP-1 Weight Loss Drug Market are Novo Nordisk, AstraZeneca, Eli Lilly, Sanofi, BENEMAE, HANSOH PHARMLA, CHIATAI TIANQING, Tonghua Dongbao Pharmaceutical, Huadong Medicine

What are the Application segmentation covered in the GLP-1 Weight Loss Drug Market report?

Ans: The Applications covered in the GLP-1 Weight Loss Drug Market report are Online Pharmacy, Offline Pharmacy

What are the Type segmentation covered in the GLP-1 Weight Loss Drug Market report?

Ans: The Types covered in the GLP-1 Weight Loss Drug Market report are Injection, Oral

Recommended Reports

GLP-1 Drug Market

Weight Management Drugs

Diabetes Related Therapies

1 GLP-1 Weight Loss Drug Market Overview
1.1 Product Definition
1.2 GLP-1 Weight Loss Drug by Type
1.2.1 Global GLP-1 Weight Loss Drug Market Value Comparison by Type (2024 VS 2031)
1.2.2 Injection
1.2.3 Oral
1.3 GLP-1 Weight Loss Drug by Application
1.3.1 Global GLP-1 Weight Loss Drug Market Value by Application (2024 VS 2031)
1.3.2 Online Pharmacy
1.3.3 Offline Pharmacy
1.4 Global GLP-1 Weight Loss Drug Market Size Estimates and Forecasts
1.4.1 Global GLP-1 Weight Loss Drug Revenue 2020-2031
1.4.2 Global GLP-1 Weight Loss Drug Sales 2020-2031
1.4.3 Global GLP-1 Weight Loss Drug Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 GLP-1 Weight Loss Drug Market Competition by Manufacturers
2.1 Global GLP-1 Weight Loss Drug Sales Market Share by Manufacturers (2020-2025)
2.2 Global GLP-1 Weight Loss Drug Revenue Market Share by Manufacturers (2020-2025)
2.3 Global GLP-1 Weight Loss Drug Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of GLP-1 Weight Loss Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of GLP-1 Weight Loss Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of GLP-1 Weight Loss Drug, Product Type & Application
2.7 Global Key Manufacturers of GLP-1 Weight Loss Drug, Date of Enter into This Industry
2.8 Global GLP-1 Weight Loss Drug Market Competitive Situation and Trends
2.8.1 Global GLP-1 Weight Loss Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest GLP-1 Weight Loss Drug Players Market Share by Revenue
2.8.3 Global GLP-1 Weight Loss Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global GLP-1 Weight Loss Drug Market Scenario by Region
3.1 Global GLP-1 Weight Loss Drug Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global GLP-1 Weight Loss Drug Sales by Region: 2020-2031
3.2.1 Global GLP-1 Weight Loss Drug Sales by Region: 2020-2025
3.2.2 Global GLP-1 Weight Loss Drug Sales by Region: 2026-2031
3.3 Global GLP-1 Weight Loss Drug Revenue by Region: 2020-2031
3.3.1 Global GLP-1 Weight Loss Drug Revenue by Region: 2020-2025
3.3.2 Global GLP-1 Weight Loss Drug Revenue by Region: 2026-2031
3.4 North America GLP-1 Weight Loss Drug Market Facts & Figures by Country
3.4.1 North America GLP-1 Weight Loss Drug Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America GLP-1 Weight Loss Drug Sales by Country (2020-2031)
3.4.3 North America GLP-1 Weight Loss Drug Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe GLP-1 Weight Loss Drug Market Facts & Figures by Country
3.5.1 Europe GLP-1 Weight Loss Drug Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe GLP-1 Weight Loss Drug Sales by Country (2020-2031)
3.5.3 Europe GLP-1 Weight Loss Drug Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific GLP-1 Weight Loss Drug Market Facts & Figures by Region
3.6.1 Asia Pacific GLP-1 Weight Loss Drug Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific GLP-1 Weight Loss Drug Sales by Region (2020-2031)
3.6.3 Asia Pacific GLP-1 Weight Loss Drug Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America GLP-1 Weight Loss Drug Market Facts & Figures by Country
3.7.1 Latin America GLP-1 Weight Loss Drug Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America GLP-1 Weight Loss Drug Sales by Country (2020-2031)
3.7.3 Latin America GLP-1 Weight Loss Drug Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa GLP-1 Weight Loss Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa GLP-1 Weight Loss Drug Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa GLP-1 Weight Loss Drug Sales by Country (2020-2031)
3.8.3 Middle East and Africa GLP-1 Weight Loss Drug Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global GLP-1 Weight Loss Drug Sales by Type (2020-2031)
4.1.1 Global GLP-1 Weight Loss Drug Sales by Type (2020-2025)
4.1.2 Global GLP-1 Weight Loss Drug Sales by Type (2026-2031)
4.1.3 Global GLP-1 Weight Loss Drug Sales Market Share by Type (2020-2031)
4.2 Global GLP-1 Weight Loss Drug Revenue by Type (2020-2031)
4.2.1 Global GLP-1 Weight Loss Drug Revenue by Type (2020-2025)
4.2.2 Global GLP-1 Weight Loss Drug Revenue by Type (2026-2031)
4.2.3 Global GLP-1 Weight Loss Drug Revenue Market Share by Type (2020-2031)
4.3 Global GLP-1 Weight Loss Drug Price by Type (2020-2031)
5 Segment by Application
5.1 Global GLP-1 Weight Loss Drug Sales by Application (2020-2031)
5.1.1 Global GLP-1 Weight Loss Drug Sales by Application (2020-2025)
5.1.2 Global GLP-1 Weight Loss Drug Sales by Application (2026-2031)
5.1.3 Global GLP-1 Weight Loss Drug Sales Market Share by Application (2020-2031)
5.2 Global GLP-1 Weight Loss Drug Revenue by Application (2020-2031)
5.2.1 Global GLP-1 Weight Loss Drug Revenue by Application (2020-2025)
5.2.2 Global GLP-1 Weight Loss Drug Revenue by Application (2026-2031)
5.2.3 Global GLP-1 Weight Loss Drug Revenue Market Share by Application (2020-2031)
5.3 Global GLP-1 Weight Loss Drug Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Company Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk GLP-1 Weight Loss Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novo Nordisk GLP-1 Weight Loss Drug Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Company Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca GLP-1 Weight Loss Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 AstraZeneca GLP-1 Weight Loss Drug Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Eli Lilly
6.3.1 Eli Lilly Company Information
6.3.2 Eli Lilly Description and Business Overview
6.3.3 Eli Lilly GLP-1 Weight Loss Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Eli Lilly GLP-1 Weight Loss Drug Product Portfolio
6.3.5 Eli Lilly Recent Developments/Updates
6.4 Sanofi
6.4.1 Sanofi Company Information
6.4.2 Sanofi Description and Business Overview
6.4.3 Sanofi GLP-1 Weight Loss Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Sanofi GLP-1 Weight Loss Drug Product Portfolio
6.4.5 Sanofi Recent Developments/Updates
6.5 BENEMAE
6.5.1 BENEMAE Company Information
6.5.2 BENEMAE Description and Business Overview
6.5.3 BENEMAE GLP-1 Weight Loss Drug Sales, Revenue and Gross Margin (2020-2025)
6.5.4 BENEMAE GLP-1 Weight Loss Drug Product Portfolio
6.5.5 BENEMAE Recent Developments/Updates
6.6 HANSOH PHARMLA
6.6.1 HANSOH PHARMLA Company Information
6.6.2 HANSOH PHARMLA Description and Business Overview
6.6.3 HANSOH PHARMLA GLP-1 Weight Loss Drug Sales, Revenue and Gross Margin (2020-2025)
6.6.4 HANSOH PHARMLA GLP-1 Weight Loss Drug Product Portfolio
6.6.5 HANSOH PHARMLA Recent Developments/Updates
6.7 CHIATAI TIANQING
6.7.1 CHIATAI TIANQING Company Information
6.7.2 CHIATAI TIANQING Description and Business Overview
6.7.3 CHIATAI TIANQING GLP-1 Weight Loss Drug Sales, Revenue and Gross Margin (2020-2025)
6.7.4 CHIATAI TIANQING GLP-1 Weight Loss Drug Product Portfolio
6.7.5 CHIATAI TIANQING Recent Developments/Updates
6.8 Tonghua Dongbao Pharmaceutical
6.8.1 Tonghua Dongbao Pharmaceutical Company Information
6.8.2 Tonghua Dongbao Pharmaceutical Description and Business Overview
6.8.3 Tonghua Dongbao Pharmaceutical GLP-1 Weight Loss Drug Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Tonghua Dongbao Pharmaceutical GLP-1 Weight Loss Drug Product Portfolio
6.8.5 Tonghua Dongbao Pharmaceutical Recent Developments/Updates
6.9 Huadong Medicine
6.9.1 Huadong Medicine Company Information
6.9.2 Huadong Medicine Description and Business Overview
6.9.3 Huadong Medicine GLP-1 Weight Loss Drug Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Huadong Medicine GLP-1 Weight Loss Drug Product Portfolio
6.9.5 Huadong Medicine Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 GLP-1 Weight Loss Drug Industry Chain Analysis
7.2 GLP-1 Weight Loss Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 GLP-1 Weight Loss Drug Production Mode & Process Analysis
7.4 GLP-1 Weight Loss Drug Sales and Marketing
7.4.1 GLP-1 Weight Loss Drug Sales Channels
7.4.2 GLP-1 Weight Loss Drug Distributors
7.5 GLP-1 Weight Loss Drug Customer Analysis
8 GLP-1 Weight Loss Drug Market Dynamics
8.1 GLP-1 Weight Loss Drug Industry Trends
8.2 GLP-1 Weight Loss Drug Market Drivers
8.3 GLP-1 Weight Loss Drug Market Challenges
8.4 GLP-1 Weight Loss Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Novo Nordisk
Astrazeneca plc
Eli Lilly
Sanofi
Benemae
Chiatai Tianqing
Tonghua Dongbao Pharmaceutical
Huadong Medicine
HANSOH PHARMLA
List of Tables
 Table 1. Global GLP-1 Weight Loss Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global GLP-1 Weight Loss Drug Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global GLP-1 Weight Loss Drug Market Competitive Situation by Manufacturers in 2024
 Table 4. Global GLP-1 Weight Loss Drug Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global GLP-1 Weight Loss Drug Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global GLP-1 Weight Loss Drug Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global GLP-1 Weight Loss Drug Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market GLP-1 Weight Loss Drug Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of GLP-1 Weight Loss Drug, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of GLP-1 Weight Loss Drug, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of GLP-1 Weight Loss Drug, Product Type & Application
 Table 12. Global Key Manufacturers of GLP-1 Weight Loss Drug, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global GLP-1 Weight Loss Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GLP-1 Weight Loss Drug as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global GLP-1 Weight Loss Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global GLP-1 Weight Loss Drug Sales by Region (2020-2025) & (K Units)
 Table 18. Global GLP-1 Weight Loss Drug Sales Market Share by Region (2020-2025)
 Table 19. Global GLP-1 Weight Loss Drug Sales by Region (2026-2031) & (K Units)
 Table 20. Global GLP-1 Weight Loss Drug Sales Market Share by Region (2026-2031)
 Table 21. Global GLP-1 Weight Loss Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global GLP-1 Weight Loss Drug Revenue Market Share by Region (2020-2025)
 Table 23. Global GLP-1 Weight Loss Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global GLP-1 Weight Loss Drug Revenue Market Share by Region (2026-2031)
 Table 25. North America GLP-1 Weight Loss Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America GLP-1 Weight Loss Drug Sales by Country (2020-2025) & (K Units)
 Table 27. North America GLP-1 Weight Loss Drug Sales by Country (2026-2031) & (K Units)
 Table 28. North America GLP-1 Weight Loss Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America GLP-1 Weight Loss Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe GLP-1 Weight Loss Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe GLP-1 Weight Loss Drug Sales by Country (2020-2025) & (K Units)
 Table 32. Europe GLP-1 Weight Loss Drug Sales by Country (2026-2031) & (K Units)
 Table 33. Europe GLP-1 Weight Loss Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe GLP-1 Weight Loss Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific GLP-1 Weight Loss Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific GLP-1 Weight Loss Drug Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific GLP-1 Weight Loss Drug Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific GLP-1 Weight Loss Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific GLP-1 Weight Loss Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America GLP-1 Weight Loss Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America GLP-1 Weight Loss Drug Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America GLP-1 Weight Loss Drug Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America GLP-1 Weight Loss Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America GLP-1 Weight Loss Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa GLP-1 Weight Loss Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa GLP-1 Weight Loss Drug Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa GLP-1 Weight Loss Drug Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa GLP-1 Weight Loss Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa GLP-1 Weight Loss Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global GLP-1 Weight Loss Drug Sales (K Units) by Type (2020-2025)
 Table 51. Global GLP-1 Weight Loss Drug Sales (K Units) by Type (2026-2031)
 Table 52. Global GLP-1 Weight Loss Drug Sales Market Share by Type (2020-2025)
 Table 53. Global GLP-1 Weight Loss Drug Sales Market Share by Type (2026-2031)
 Table 54. Global GLP-1 Weight Loss Drug Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global GLP-1 Weight Loss Drug Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global GLP-1 Weight Loss Drug Revenue Market Share by Type (2020-2025)
 Table 57. Global GLP-1 Weight Loss Drug Revenue Market Share by Type (2026-2031)
 Table 58. Global GLP-1 Weight Loss Drug Price (US$/Unit) by Type (2020-2025)
 Table 59. Global GLP-1 Weight Loss Drug Price (US$/Unit) by Type (2026-2031)
 Table 60. Global GLP-1 Weight Loss Drug Sales (K Units) by Application (2020-2025)
 Table 61. Global GLP-1 Weight Loss Drug Sales (K Units) by Application (2026-2031)
 Table 62. Global GLP-1 Weight Loss Drug Sales Market Share by Application (2020-2025)
 Table 63. Global GLP-1 Weight Loss Drug Sales Market Share by Application (2026-2031)
 Table 64. Global GLP-1 Weight Loss Drug Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global GLP-1 Weight Loss Drug Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global GLP-1 Weight Loss Drug Revenue Market Share by Application (2020-2025)
 Table 67. Global GLP-1 Weight Loss Drug Revenue Market Share by Application (2026-2031)
 Table 68. Global GLP-1 Weight Loss Drug Price (US$/Unit) by Application (2020-2025)
 Table 69. Global GLP-1 Weight Loss Drug Price (US$/Unit) by Application (2026-2031)
 Table 70. Novo Nordisk Company Information
 Table 71. Novo Nordisk Description and Business Overview
 Table 72. Novo Nordisk GLP-1 Weight Loss Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Novo Nordisk GLP-1 Weight Loss Drug Product
 Table 74. Novo Nordisk Recent Developments/Updates
 Table 75. AstraZeneca Company Information
 Table 76. AstraZeneca Description and Business Overview
 Table 77. AstraZeneca GLP-1 Weight Loss Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. AstraZeneca GLP-1 Weight Loss Drug Product
 Table 79. AstraZeneca Recent Developments/Updates
 Table 80. Eli Lilly Company Information
 Table 81. Eli Lilly Description and Business Overview
 Table 82. Eli Lilly GLP-1 Weight Loss Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Eli Lilly GLP-1 Weight Loss Drug Product
 Table 84. Eli Lilly Recent Developments/Updates
 Table 85. Sanofi Company Information
 Table 86. Sanofi Description and Business Overview
 Table 87. Sanofi GLP-1 Weight Loss Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Sanofi GLP-1 Weight Loss Drug Product
 Table 89. Sanofi Recent Developments/Updates
 Table 90. BENEMAE Company Information
 Table 91. BENEMAE Description and Business Overview
 Table 92. BENEMAE GLP-1 Weight Loss Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. BENEMAE GLP-1 Weight Loss Drug Product
 Table 94. BENEMAE Recent Developments/Updates
 Table 95. HANSOH PHARMLA Company Information
 Table 96. HANSOH PHARMLA Description and Business Overview
 Table 97. HANSOH PHARMLA GLP-1 Weight Loss Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. HANSOH PHARMLA GLP-1 Weight Loss Drug Product
 Table 99. HANSOH PHARMLA Recent Developments/Updates
 Table 100. CHIATAI TIANQING Company Information
 Table 101. CHIATAI TIANQING Description and Business Overview
 Table 102. CHIATAI TIANQING GLP-1 Weight Loss Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. CHIATAI TIANQING GLP-1 Weight Loss Drug Product
 Table 104. CHIATAI TIANQING Recent Developments/Updates
 Table 105. Tonghua Dongbao Pharmaceutical Company Information
 Table 106. Tonghua Dongbao Pharmaceutical Description and Business Overview
 Table 107. Tonghua Dongbao Pharmaceutical GLP-1 Weight Loss Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Tonghua Dongbao Pharmaceutical GLP-1 Weight Loss Drug Product
 Table 109. Tonghua Dongbao Pharmaceutical Recent Developments/Updates
 Table 110. Huadong Medicine Company Information
 Table 111. Huadong Medicine Description and Business Overview
 Table 112. Huadong Medicine GLP-1 Weight Loss Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Huadong Medicine GLP-1 Weight Loss Drug Product
 Table 114. Huadong Medicine Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. GLP-1 Weight Loss Drug Distributors List
 Table 118. GLP-1 Weight Loss Drug Customers List
 Table 119. GLP-1 Weight Loss Drug Market Trends
 Table 120. GLP-1 Weight Loss Drug Market Drivers
 Table 121. GLP-1 Weight Loss Drug Market Challenges
 Table 122. GLP-1 Weight Loss Drug Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of GLP-1 Weight Loss Drug
 Figure 2. Global GLP-1 Weight Loss Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global GLP-1 Weight Loss Drug Market Share by Type: 2024 & 2031
 Figure 4. Injection Product Picture
 Figure 5. Oral Product Picture
 Figure 6. Global GLP-1 Weight Loss Drug Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global GLP-1 Weight Loss Drug Market Share by Application: 2024 & 2031
 Figure 8. Online Pharmacy
 Figure 9. Offline Pharmacy
 Figure 10. Global GLP-1 Weight Loss Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global GLP-1 Weight Loss Drug Market Size (2020-2031) & (US$ Million)
 Figure 12. Global GLP-1 Weight Loss Drug Sales (2020-2031) & (K Units)
 Figure 13. Global GLP-1 Weight Loss Drug Average Price (US$/Unit) & (2020-2031)
 Figure 14. GLP-1 Weight Loss Drug Report Years Considered
 Figure 15. GLP-1 Weight Loss Drug Sales Share by Manufacturers in 2024
 Figure 16. Global GLP-1 Weight Loss Drug Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest GLP-1 Weight Loss Drug Players: Market Share by Revenue in GLP-1 Weight Loss Drug in 2024
 Figure 18. GLP-1 Weight Loss Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global GLP-1 Weight Loss Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America GLP-1 Weight Loss Drug Sales Market Share by Country (2020-2031)
 Figure 21. North America GLP-1 Weight Loss Drug Revenue Market Share by Country (2020-2031)
 Figure 22. United States GLP-1 Weight Loss Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada GLP-1 Weight Loss Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe GLP-1 Weight Loss Drug Sales Market Share by Country (2020-2031)
 Figure 25. Europe GLP-1 Weight Loss Drug Revenue Market Share by Country (2020-2031)
 Figure 26. Germany GLP-1 Weight Loss Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France GLP-1 Weight Loss Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. GLP-1 Weight Loss Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy GLP-1 Weight Loss Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia GLP-1 Weight Loss Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific GLP-1 Weight Loss Drug Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific GLP-1 Weight Loss Drug Revenue Market Share by Region (2020-2031)
 Figure 33. China GLP-1 Weight Loss Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan GLP-1 Weight Loss Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea GLP-1 Weight Loss Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India GLP-1 Weight Loss Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia GLP-1 Weight Loss Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan GLP-1 Weight Loss Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia GLP-1 Weight Loss Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America GLP-1 Weight Loss Drug Sales Market Share by Country (2020-2031)
 Figure 41. Latin America GLP-1 Weight Loss Drug Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico GLP-1 Weight Loss Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil GLP-1 Weight Loss Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina GLP-1 Weight Loss Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Middle East and Africa GLP-1 Weight Loss Drug Sales Market Share by Country (2020-2031)
 Figure 46. Middle East and Africa GLP-1 Weight Loss Drug Revenue Market Share by Country (2020-2031)
 Figure 47. Turkey GLP-1 Weight Loss Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia GLP-1 Weight Loss Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. UAE GLP-1 Weight Loss Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Global Sales Market Share of GLP-1 Weight Loss Drug by Type (2020-2031)
 Figure 51. Global Revenue Market Share of GLP-1 Weight Loss Drug by Type (2020-2031)
 Figure 52. Global GLP-1 Weight Loss Drug Price (US$/Unit) by Type (2020-2031)
 Figure 53. Global Sales Market Share of GLP-1 Weight Loss Drug by Application (2020-2031)
 Figure 54. Global Revenue Market Share of GLP-1 Weight Loss Drug by Application (2020-2031)
 Figure 55. Global GLP-1 Weight Loss Drug Price (US$/Unit) by Application (2020-2031)
 Figure 56. GLP-1 Weight Loss Drug Value Chain
 Figure 57. Channels of Distribution (Direct Vs Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global GLP 1 Weight Loss Pill Market Research Report 2024
GLP 1 for Weight Loss Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global GLP 1 Weight Loss Injection Market Research Report 2024
Global GLP 1 Agonists for Obesity Market Research Report 2024
Global GLP 1 Drug Peptide API Market Research Report 2024
Global GLP 1 based Therapy Market Research Report 2024
GLP 1 for Diabetes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global GLP 1 Peptide Drugs Market Research Report 2024
GLP 1 Analogues Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global GLP 1 Injection Market Research Report 2024
Global GLP 1 Agonists for the Treatment of both Diabetes and Obesity Market Research Report 2024
Global GLP 1RA Therapy Market Research Report 2024
Global GLP 1 Receptor Agonist Drugs Market Research Report 2024
Global Oral GLP 1 Agonist Market Research Report 2024
Global Glucagon Like Peptide 1 GLP 1 Agonists Market Research Report 2025
Global Glucagon like peptide 1 GLP 1 based Therapies Market Research Report 2025
Global Antidiabetic Glucagon like Peptide 1 Agonists Market Research Report 2025
Global Liraglutide for The Treatment of Diabetes and Obesity Market Research Report 2024
GLP Analogs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global GLP 1 Receptor Antagonist Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions